CASI Pharmaceuticals Inc (CASI) — Cash Flow-to-Debt Ratio
CASI Pharmaceuticals Inc (CASI) has a Cash Flow-to-Debt Ratio of -0.03x as of March 2023, meaning its operating cash flow of $-843.00K could theoretically repay 0% of its total liabilities ($26.17 Million) in one year. See free cash flow generation of CASI Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CASI Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1994–2024)
Historical debt coverage capacity for CASI Pharmaceuticals Inc across 31 annual periods. Also explore CASI Pharmaceuticals Inc (CASI) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for CASI Pharmaceuticals Inc (1994–2024)
Year-by-year debt coverage analysis for CASI Pharmaceuticals Inc. For market capitalisation and broader financial context, see CASI company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.56x | $-29.22 Million | $51.82 Million | ▼ -44.3% |
| 2023 | -0.39x | $-19.97 Million | $51.10 Million | ▲ +45.7% |
| 2022 | -0.72x | $-21.09 Million | $29.30 Million | ▲ +18.7% |
| 2021 | -0.88x | $-26.84 Million | $30.34 Million | ▲ +17.4% |
| 2020 | -1.07x | $-25.89 Million | $24.16 Million | ▲ +58.7% |
| 2019 | -2.59x | $-23.24 Million | $8.97 Million | ▲ +64.2% |
| 2018 | -7.24x | $-28.58 Million | $3.95 Million | ▼ -642.0% |
| 2017 | -0.98x | $-6.40 Million | $6.56 Million | ▼ -12.3% |
| 2016 | -0.87x | $-6.02 Million | $6.93 Million | ▼ -87.8% |
| 2015 | -0.46x | $-5.51 Million | $11.91 Million | ▼ -35.9% |
| 2014 | -0.34x | $-4.00 Million | $11.73 Million | ▲ +94.1% |
| 2013 | -5.80x | $-3.28 Million | $565.17K | ▼ -94.6% |
| 2012 | -2.98x | $-2.21 Million | $742.75K | ▲ +50.9% |
| 2011 | -6.07x | $-4.27 Million | $704.09K | ▼ -230.8% |
| 2010 | -1.83x | $-4.96 Million | $2.70 Million | ▼ -115.4% |
| 2009 | -0.85x | $-10.21 Million | $11.99 Million | ▲ +5.4% |
| 2008 | -0.90x | $-20.71 Million | $23.00 Million | ▲ +0.0% |
| 2007 | -0.90x | $-23.52 Million | $26.12 Million | ▲ +62.1% |
| 2006 | -2.38x | $-20.77 Million | $8.74 Million | ▼ -15.4% |
| 2005 | -2.06x | $-14.52 Million | $7.05 Million | ▲ +53.8% |
| 2004 | -4.46x | $-16.41 Million | $3.68 Million | ▲ +3.0% |
| 2003 | -4.59x | $-24.25 Million | $5.28 Million | ▼ -74.6% |
| 2002 | -2.63x | $-45.53 Million | $17.30 Million | ▼ -14.5% |
| 2001 | -2.30x | $-52.87 Million | $23.01 Million | ▲ +35.8% |
| 2000 | -3.58x | $-44.25 Million | $12.35 Million | ▲ +1.9% |
| 1999 | -3.65x | $-35.80 Million | $9.80 Million | ▼ -87.0% |
| 1998 | -1.95x | $-12.50 Million | $6.40 Million | ▼ -68.7% |
| 1997 | -1.16x | $-6.60 Million | $5.70 Million | ▼ -236.8% |
| 1996 | -0.34x | $-2.20 Million | $6.40 Million | ▲ +49.7% |
| 1995 | -0.68x | $-4.44 Million | $6.50 Million | ▲ +90.6% |
| 1994 | -7.25x | $-4.35 Million | $600.00K | — |